Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tiny Ultra-Flexible Endovascular Probe Records Deep-Brain Activity without Cranial Surgery

By HospiMedica International staff writers
Posted on 25 Jul 2023

Brain-Machine Interfaces (BMIs) facilitate direct electrical communication between the brain and external electronic systems, allowing brain activity to directly control devices such as prosthetics or control nerve or muscle function. More...

This is particularly helpful for those with paralysis or neurological disorders in regaining function. However, traditional BMIs are often restricted to assessing neural activity on the brain's surface. Monitoring single-neuron activity from deep brain areas usually requires invasive intracranial surgeries to embed probes, potentially leading to the risk of infection, inflammation, and damage to brain tissues. An innovative alternative involves utilizing the brain's vascular network to implant bio-probes into deep-brain regions. Researchers have now devised an ultra-small, ultra-flexible electronic neural implant that can be delivered via blood vessels and is capable of recording single-neuron activity from deep within rat brains.

Researchers at Stanford University (Stanford, CA, USA) have designed ultra-flexible micro-endovascular (MEV) probes that can be accurately delivered to deep-brain areas through the blood vessels. The researchers built a minute, flexible, mesh-like electronic recording device that can be mounted onto a flexible microcatheter and implanted into sub-100-micron scale blood vessels in the brain's inner areas. Once inserted, the device expands like a stent to record neuronal signals across the vascular wall without causing damage to the brain or its blood vessels.

To assess the potential of the MEV probe in vivo, the researchers implanted the injectable probe into the vascular system of rat brains. The MEV probe demonstrated the capability to measure local field potentials and single-neuron activity in the cortex and olfactory bulb. Furthermore, the implanted devices demonstrated long-term stability, did not cause significant changes to cerebral blood flow or rat behavior, and triggered a minimal immune response. According to the researchers, future versions of these devices could even offer customized therapies to patients by recording and decoding their neural activity, followed by delivery of the appropriate modulatory stimuli.

Related Links:
Stanford University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.